February 10, 2021 Cerevance Appoints Naidong Ye, Ph.D. as Vice President and Head of Chemistry, Manufacturing and Controls
November 16, 2020 Cerevance’s CVN058 Achieves Primary Endpoint in Phase 1b Schizophrenia Cognition Study
January 7, 2020 Cerevance Appoints Clinical Development Veteran Dr. Aoife Brennan to Board of Directors
December 17, 2019 Cerevance Enters Research Collaboration with Takeda to Advance New Treatments for Gastrointestinal Disorders
